Collectively, these discoveries highlight the therapeutic potential of chrysophanol in combating obesity and related metabolic disorders by virtue of its ability to upregulate SIRT6, subsequently promoting the upregulation of PGC-1α and UCP-1 in BAT (Liu et al., 2020). Here, UCP1 is linked to Obesity.